175 related articles for article (PubMed ID: 33484628)
1. Digital therapeutics for essential hypertension using a smartphone application: A randomized, open-label, multicenter pilot study.
Kario K; Nomura A; Kato A; Harada N; Tanigawa T; So R; Suzuki S; Hida E; Satake K
J Clin Hypertens (Greenwich); 2021 May; 23(5):923-934. PubMed ID: 33484628
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.
Kario K; Nomura A; Harada N; Okura A; Nakagawa K; Tanigawa T; Hida E
Eur Heart J; 2021 Oct; 42(40):4111-4122. PubMed ID: 34455443
[TBL] [Abstract][Full Text] [Related]
3. A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB-DH1 trial.
Kario K; Nomura A; Harada N; Tanigawa T; So R; Nakagawa K; Suzuki S; Okura A; Hida E; Satake K
J Clin Hypertens (Greenwich); 2020 Sep; 22(9):1713-1722. PubMed ID: 32815648
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
Lacourcière Y; Neutel JM; Davidai G; Koval S
Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
[TBL] [Abstract][Full Text] [Related]
7. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
Punzi HA
Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of clinical arterial pressure, home-arterial pressure measurement, and ambulatory arterial pressure monitoring in patients with type II diabetes mellitus and diabetic nephropathy].
Lou LM; Gimeno JA; Gómez Sánchez R; Labrador T; Beguer P; Lou MT; Boned B; Aguilar E
Nefrologia; 2002; 22(2):179-89. PubMed ID: 12085419
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
[TBL] [Abstract][Full Text] [Related]
13. [Comparative Efficacy of the Influence of Fixed Combinations of Antihypertensive Drugs That Block the Renin-Angiotensin-Aldosterone System, With Thiazide Diuretics on the Parameters of Ambulatory Blood Pressure Monitoring].
Ostroumova OD; Garelik IA
Kardiologiia; 2016 Dec; 56(12):20-26. PubMed ID: 28290800
[TBL] [Abstract][Full Text] [Related]
14. Morning versus evening administration of a calcium channel blocker in combination therapy for essential hypertension by ambulatory blood pressure monitoring analysis.
Chu CS; Lee KT; Chen SH; Lu YH; Lin TH; Voon WC; Sheu SH; Lai WT
Int Heart J; 2005 May; 46(3):433-42. PubMed ID: 16043939
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
16. The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
Giles TD; Oparil S; Ofili EO; Pitt B; Purkayastha D; Hilkert R; Samuel R; Sowers JR
Blood Press Monit; 2011 Apr; 16(2):87-95. PubMed ID: 21386706
[TBL] [Abstract][Full Text] [Related]
17. Achieving blood pressure control targets in hypertensive patients of rural China - a pilot randomized trial.
Huang X; Liu L; Song Y; Gao L; Zhao M; Bao H; Qin X; Wu Y; Wu Q; Bi C; Yue A; Fang C; Ma H; Cui Y; Tang G; Li P; Zhang Y; Li J; Wang B; Xu X; Wang H; Parati G; Spence JD; Wang X; Huo Y; Chen G; Cheng X;
Trials; 2020 Jun; 21(1):515. PubMed ID: 32527283
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
Chrysant SG; Marbury TC; Robinson TD
J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
[TBL] [Abstract][Full Text] [Related]
19. Study of sustained blood pressure-lowering effect of azelnidipine guided by self-measured morning and evening home blood pressure: subgroup analysis of the At-HOME study.
Kario K; Uehara Y; Shirayama M; Takahashi M; Shiosakai K; Hiramatsu K; Komiya M; Shimada K
Drugs R D; 2013 Mar; 13(1):75-85. PubMed ID: 23519655
[TBL] [Abstract][Full Text] [Related]
20. Smartphone Application-Assisted Home Blood Pressure Monitoring Compared With Office and Ambulatory Blood Pressure Monitoring in Patients With Hypertension: the AMUSE-BP Study.
Groenland EH; Vendeville JAC; Bemelmans RHH; Monajemi H; Bots ML; Visseren FLJ; Spiering W
Hypertension; 2022 Oct; 79(10):2373-2382. PubMed ID: 35959685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
